Beijing Winsunny Pharmaceutical CO.LTD (601089) — Financial Flexibility Index
Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Financial Flexibility Index of 0.86x as of December 2024. Free cash flow of CN¥1.08 Billion (operating CF CN¥690.75 Million minus capex CN¥391.52 Million) represents 1% of total liabilities (CN¥1.26 Billion). Also explore Beijing Winsunny Pharmaceutical CO.LTD (601089) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Winsunny Pharmaceutical CO.LTD Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. Check Beijing Winsunny Pharmaceutical CO.LTD asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)
Year-by-year free cash flow to debt coverage for Beijing Winsunny Pharmaceutical CO.LTD. For the full company profile including market capitalisation, see Beijing Winsunny Pharmaceutical CO.LTD market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.86x | CN¥1.08 Billion | CN¥690.75 Million | CN¥1.26 Billion | ▼ -0.2% |
| 2023 | 0.86x | CN¥921.98 Million | CN¥555.90 Million | CN¥1.07 Billion | ▲ +23.7% |
| 2022 | 0.70x | CN¥795.17 Million | CN¥659.76 Million | CN¥1.14 Billion | ▼ -9.5% |
| 2021 | 0.77x | CN¥721.00 Million | CN¥528.02 Million | CN¥937.86 Million | ▼ -1.9% |
| 2020 | 0.78x | CN¥555.62 Million | CN¥386.65 Million | CN¥709.01 Million | — |